What insurance policy changes affect HCPCS S0390?

There are 7 tracked policy changes affecting HCPCS S0390, including updates from Capital Blue Cross, Aetna, Independence Blue Cross. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for HCPCS S0390?

Payers that have issued tracked updates for HCPCS S0390 include: Capital Blue Cross, Aetna, Independence Blue Cross.

How do I get notified when HCPCS S0390 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to HCPCS S0390. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for HCPCS S0390?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

S0390 — Routine foot care; removal and/or trimming of corns, calluses and/or nails and preventive maintenance in specific medical conditions (e.g., diabetes), per visit: Insurance Policy Changes

S0390 Insurance Policy Changes

HCPCS S0390 is officially defined as "Routine foot care; removal and/or trimming of corns, calluses and/or nails and preventive maintenance in specific medical conditions (e.g., diabetes), per visit." HCPCS S0390 is referenced in 7 tracked payer policy changes from Capital Blue Cross, Aetna, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS S0390 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

High impact

AB2026-09-005 Medical policies

Capital Blue Cross·Effective Oct 1, 2026

Capital Blue Cross has updated 50+ medical specialty injectable policies and several general medical policies effective October 1 and November 1, 2026. New prior authorization requirements apply to Decnupaz (J9999, C9399) and new biosimilars Filkri and Immgolis Intri. Medical specialty injectable policies have been delegated to Prime Therapeutics (MPS) with updated clinical criteria and a new online submission portal (GatewayPA). Billing teams must identify affected injectable medications in their patient population and implement new prior authorization workflows.

S0390 Insurance Policy Changes

AB2026-09-005 Medical policies

Routine Foot Care (CPB 0046, reviewed 2026-04-07)

MA07.009j, Routine Foot Care for Certain Medical Conditions

MA07.009j, Routine Foot Care for Certain Medical Conditions

07.07.01r, Routine Foot Care for Certain Medical Conditions

07.07.01r, Routine Foot Care for Certain Medical Conditions

MA07.009i, Routine Foot Care for Certain Medical Conditions